V. KORTEN Et Al. , "Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: Data from the Turkish HIV-TR Cohort," EACS 2019 , 2019
KORTEN, V. Et Al. 2019. Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: Data from the Turkish HIV-TR Cohort. EACS 2019 .
KORTEN, V., İnan, A., AKALIN, E. H., GÖKENGİN, A. D., KAYA, B., İNAN, D., ... ÖZKAN ÖZDEMİR, H.(2019). Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: Data from the Turkish HIV-TR Cohort . EACS 2019
KORTEN, VOLKAN Et Al. "Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: Data from the Turkish HIV-TR Cohort," EACS 2019, 2019
KORTEN, VOLKAN Et Al. "Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: Data from the Turkish HIV-TR Cohort." EACS 2019 , 2019
KORTEN, V. Et Al. (2019) . "Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: Data from the Turkish HIV-TR Cohort." EACS 2019 .
@conferencepaper{conferencepaper, author={VOLKAN KORTEN Et Al. }, title={Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: Data from the Turkish HIV-TR Cohort}, congress name={EACS 2019}, city={}, country={}, year={2019}}